.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Risk awareness more important than ever for isotretinoin

November 1, 2004

New York - Discussing "What's Up with Isotretinoin" at the recent American Academy of Dermatology Academy '04 here, John S. Strauss, M.D., reported that much of the recent attention on oral retinoids continues to focus on the pregnancy risk management aspects of its use for the treatment of acne.